CBRAIN (CBRAIN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Achieved strong progress on the 2023-2025 Growth Plan, with revenue and earnings on track to meet or exceed internal targets.
Revenue increased by 6% to DKK 139m in H1 2024, with Danish sales up 21% and international sales down 13% due to timing of license recognition.
Strategic focus on becoming a global leader in commercial off-the-shelf (COTS) software for government, leveraging a unique, fully integrated platform.
Growth driven by software subscriptions, strategic customers, and the F2-for-Partners strategy, with 80% of revenue from software sales.
Expanded international presence with new contracts and partnerships in Germany, the US, Romania, Ghana, India, UAE, Kenya, and Nigeria.
Financial highlights
1H 2024 revenue reached DKK 139m, up 6% year-over-year; software sales DKK 111m (up 5%), services DKK 28m (up 7%).
Earnings before tax (EBT) margin at 31% for 1H 2024; EBT DKK 43m (down 8% year-over-year).
Net profit: DKK 32m (down from DKK 36m in H1 2023).
Cash flow from operations: DKK 11m; cash and equivalents: DKK 2m; trade receivables: DKK 74m.
Total equity: DKK 256m (up DKK 54m year-over-year); solvency ratio: 69%.
Outlook and guidance
Revenue forecast for 2024 is DKK 287–299m, targeting 20–25% growth; EBT margin guidance for 2024 is 20–30%.
On track to achieve DKK 350m revenue and 30% EBT margin by 2025.
International sales expected to accelerate in H2 2024 as strategic projects mature.
Continued growth expected in Denmark, with increased investments in public tenders and bid management.
Latest events from CBRAIN
- 2025 saw a 6% revenue drop but strong subscription growth and a 56% dividend hike.CBRAIN
Q4 202519 Feb 2026 - Growth strategy pivots to global COTS niches, backed by strong financials and partnerships.CBRAIN
Q1 202528 Jan 2026 - Subscription revenue up 24% and international business now one-third of total revenue.CBRAIN
Q3 202517 Nov 2025 - Revenue down 5%, but recurring revenue up 24% and global expansion continues.CBRAIN
Q2 202510 Oct 2025 - 1H 2024 revenue up 6% to DKK 139m; global F2 expansion drives 2025 growth target.CBRAIN
Q3 202413 Jun 2025 - 2024 saw double-digit growth and global expansion, with a 32% EBT margin and strong outlook.CBRAIN
Q4 20245 Jun 2025